Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled
its third quarter conference call for 8:30 a.m. ET on Thursday, October
31, 2013. The schedules for the press release and conference call are as
follows:
|
|
|
|
-- Q3 2013 Press Release:
|
|
|
|
|
|
|
|
October 31, 2013 at 7:00 a.m. ET
|
|
|
|
|
-- Q3 2013 Conference Call:
|
|
|
|
|
|
|
|
October 31, 2013 at 8:30 a.m. ET
|
|
|
|
|
-- Domestic Dial In Number:
|
|
|
|
|
|
|
|
877-407-8037
|
|
|
|
|
-- International Dial In Number:
|
|
|
|
|
|
|
|
201-689-8037
|
|
|
|
|
-- Conference ID #
|
|
|
|
|
|
|
|
421882
|
If you are unable to participate, a replay of the conference call will
be available for thirty days. The replay dial-in number for the U.S. is
877-660-6853 and dial-in number for international callers is
201-612-7415. To access the replay you will need the conference ID
number 421882.
The conference call will also be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts.
About Incyte
Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical
company focused on the discovery, development and commercialization of
proprietary small molecule drugs for oncology and inflammation. For
additional information on Incyte, please visit the Company's web site at www.incyte.com.
Copyright Business Wire 2013